ANI Pharmaceuticals
Price & Volume
Stats
See more52W Range | $57.33-$99.50 |
Market Cap | $1.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $923.7M |
Revenue Growth (YoY) | 20.5% |
Gross Profit (12 Mos) | $561.8M |
Diluted EPS | $3.91 |
News
See moreYahoo Finance • 9 days ago
ANI Pharmaceuticals Refocuses On Rare Disease As Buybacks And Insider Sales Rise
Yahoo Finance • 28 days ago
Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks
Yahoo Finance • last month
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
Yahoo Finance • last month
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
About
CFO | Mr. Stephen P. Carey |
Address | 210 Main Street West, Baudette, MN, United States, 56623 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 970 |